Aprea Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $86.97K.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $121.43K.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2020-03-31 was $29.52K, a 27.71% increase year-over-year.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2019-06-30 was $0.00.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $208.37K, a 38.04% increase from fiscal 2020.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $150.95K, a 112.61% increase from fiscal 2019.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $71.00K, a 3285.65% increase from fiscal 2018.
- Aprea Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $2.10K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $208.37K 10-K · filed 2024-03-26 | |
| 2021-09-30 | $86.97K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $150.95K 10-K · filed 2023-03-30 | |
| 2020-06-30 | $121.43K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $29.52K 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $71.00K 10-K · filed 2022-03-15 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | |
| 2019-03-31 | $23.12K 10-Q · filed 2020-08-11 | |
| 2018-12-31 | $2.10K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |